A phase I/randomized phase II study of GM.CD40L vaccine in combination with CCL21 in patients with advanced lung adenocarcinoma
Gray, Jhanelle E., Chiappori, Alberto, Williams, Charlie C., Tanvetyanon, Tawee, Haura, Eric B., Creelan, Ben C., Kim, Jongphil, Boyle, Theresa A., Pinder-Schenck, Mary, Khalil, Farah, Altiok, Soner,Language:
english
Journal:
Cancer Immunology, Immunotherapy
DOI:
10.1007/s00262-018-2236-7
Date:
September, 2018
File:
PDF, 1.04 MB
english, 2018